Search Results for: lxrp

Has patents in the United States and Australia and patents pending in more than 40 countries for proprietary technology easing how edible cannabinoids enter body Revenue stream comes from own products and 5-10% margin of gross sales from licensing technology to third parties Signed C$250,000 joint venture agreement with National Research Council (NRC) in Canada … Continue reading “Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sees New Round of Investors Attracted to Cannabis Market”

Cannabidiol (CBD) combats anxiety, inflammation, nausea and vomiting Low side-effect profile means high doses of cannabidiol can be used for treatment of schizophrenia, dementia, diabetes and nausea Lower doses promote and maintain health with anti-oxidative, anti-inflammatory and neuroprotective effects Lexaria Bioscience Corp. set to benefit from increasing interest in CBD as patented technology improves taste, … Continue reading “Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Set to Benefit as Study Shows More Benefits of Cannabidiol”

Patented lipophilic delivery system increases bio-absorption Patents cover broad range of lipophilic bio-actives, including cannabinoids, vitamins, other pharma 19 patents filed across 44 countries First international patent issued and approved in Australia Any argument over the efficacy of medicinal marijuana is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are … Continue reading “Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Patented Cannabinoid Delivery System Approved”

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced the start of laboratory work under its collaborative research project with the National Research Council of Canada (“NRC”). “We are delighted to have commenced formulation development and characterization work together with the NRC,” John Docherty, president of Lexaria Bioscience, stated in the news release. “The … Continue reading “QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Commences Lab Work with National Research Council of Canada”

Lexaria Bioscience Corp. well-positioned for growth in expanding Canadian cannabinoid market Canadian market for cannabis extracts and oils expected to top C$1.6 billion by 2020 Company’s patented technology infuses organically sourced hemp oil into molecules of other substances such as lipids, the basis of the human endocannabinoid system Patented technology enables better-tasting hemp oil-infused gourmet … Continue reading “Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Well-positioned For Expanding Canadian Cannabinoid Market”

Revenue-generating biosciences company focused on improving the delivery of bioactive compounds through gourmet foods Proprietary technology shown to enhance the bioavailability of orally ingested cannabinoids while improving the taste Actively developing and selling hemp oil-based gourmet food products through consumer brands ViPova™ and Lexaria Energy Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and … Continue reading “Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch””